Terms: = Lung cancer AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Prognosis
12 results:
1. Deciphering the heterogeneity of neutrophil cells within circulation and the lung cancer microenvironment pre- and post-operation.
Liu F; Liu X; Liu Y; Chen D; Liu X; Qin C; Song Y; Fang H; Wu D
Cell Biol Toxicol; 2024 Feb; 40(1):11. PubMed ID: 38319415
[TBL] [Abstract] [Full Text] [Related]
2. Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma.
Liu ZT; Shen JT; Lei YJ; Huang YC; Zhao GQ; Zheng CH; Wang X; Wang YT; Chen L; Li ZX; Li SZ; Liao J; Yu TD
BMC Cancer; 2023 Nov; 23(1):1141. PubMed ID: 38001428
[TBL] [Abstract] [Full Text] [Related]
3. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
[TBL] [Abstract] [Full Text] [Related]
4. Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma.
Song C; Lu Z; Lai K; Li D; Hao B; Xu C; Pan S; Li N; Geng Q
Sci Rep; 2022 Jun; 12(1):10110. PubMed ID: 35710585
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma.
Yang H; Berezowska S; Dorn P; Zens P; Chen P; Peng RW; Marti TM; Kocher GJ; Schmid RA; Hall SRR
Theranostics; 2022; 12(1):167-185. PubMed ID: 34987640
[No Abstract] [Full Text] [Related]
6. Genomic comparison between cerebrospinal fluid and primary tumor revealed the genetic events associated with brain metastasis in lung adenocarcinoma.
Deng Z; Cui L; Li P; Ren N; Zhong Z; Tang Z; Wang L; Gong J; Cheng H; Guan Y; Yi X; Xia X; Zhou R; He Z
Cell Death Dis; 2021 Oct; 12(10):935. PubMed ID: 34642306
[TBL] [Abstract] [Full Text] [Related]
7. An Inflammation-Related Nine-Gene Signature to Improve prognosis Prediction of lung Adenocarcinoma.
Liu ZJ; Hou PX; Wang XX
Dis Markers; 2021; 2021():9568057. PubMed ID: 34580602
[TBL] [Abstract] [Full Text] [Related]
8. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract] [Full Text] [Related]
9. Interleukin 7 receptor activates PI3K/Akt/mTOR signaling pathway via downregulation of Beclin-1 in lung cancer.
Jian M; Yunjia Z; Zhiying D; Yanduo J; Guocheng J
Mol Carcinog; 2019 Mar; 58(3):358-365. PubMed ID: 30362635
[TBL] [Abstract] [Full Text] [Related]
10. Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?
Lindskog C; Edlund K; Mattsson JS; Micke P
Expert Rev Mol Diagn; 2015 Apr; 15(4):471-90. PubMed ID: 25599124
[TBL] [Abstract] [Full Text] [Related]
11. [The expressions of IL-7 and IL-7R and the relationship between them with lymph node metastasis and prognosis in non-small cell lung cancer].
MING J; ZHANG Q; JIANG Y; QIU X; BAI X
Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1101-6. PubMed ID: 21159243
[TBL] [Abstract] [Full Text] [Related]
12. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer.
Ming J; Zhang Q; Qiu X; Wang E
Eur J Cancer; 2009 Mar; 45(5):866-73. PubMed ID: 19136250
[TBL] [Abstract] [Full Text] [Related]